Skip to content

Nonacog alfa

BeneFIX (nonacog alfa) is a protein pharmaceutical. Nonacog alfa was first approved as BeneFIX on 1997-08-27. It is used to treat factor VII deficiency, hemophilia a, hemophilia b, and hypoprothrombinemias in the USA. It has been approved in Europe to treat hemophilia b.
Trade Name BeneFIX
Common Name Nonacog alfa
Indication factor vii deficiency, hemophilia a, hemophilia b, hypoprothrombinemias
Drug Class
Nonacog alfa
Get full access now